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Dermal Fibroblasts Promote the Migration of
Dendritic Cells
Anja Saalbach1, Claudia Klein1, Christine Schirmer1,3, Wilfried Briest2, Ulf Anderegg1 and Jan C. Simon1
Migration of dendritic cells (DCs) from skin to lymph nodes on activation is an essential step in the initiation of
an adequate immune response. The dermal microenvironment including stromal cells and their soluble factors
might be involved in the regulation of DC migration. To focus on the role of dermal fibroblasts, we studied
whether interaction of DCs with fibroblasts promotes the migration of DCs. DCs were co-cultured with resting
fibroblasts or with tumor necrosis factor (TNF)a/IL-1b-activated fibroblasts to mimic an inflammatory
microenvironment. Interaction of DCs with TNFa/IL-1b-stimulated fibroblasts increased the secretion of matrix
metalloproteinase-9 (MMP-9) from DCs within 6 hours compared with DCs alone or DCs stimulated with
lipopolysaccharide or TNFa/IL-1b. In contrast, unstimulated fibroblasts did not affect MMP-9 secretion. IL-6
released by TNFa/IL-1b-stimulated fibroblasts was identified as a factor responsible for fibroblast-stimulated
MMP-9 secretion from DCs. In accordance with the elevated MMP-9 release, on co-culture with TNFa/IL-1b-
stimulated fibroblasts, DCs migrated significantly more effectively through matrigel matrices than did TNFa/IL-
1b-stimulated DCs. This was inhibited by a selective blocking of MMP-9, indicating the importance of MMP-9 for
this migratory capacity of DCs. In summary, fibroblasts in the local dermal microenvironment are capable of
potentiating the migratory capacity of DCs, and thus have the potential to actively participate in the regulation
of a cutaneous immune response.
Journal of Investigative Dermatology (2010) 130, 444–454; doi:10.1038/jid.2009.253; published online 27 August 2009
INTRODUCTION
Dendritic cells (DCs) are professional antigen-presenting cells
found in an immature stage in epithelia and in the interstitial
space of most solid organs, where they capture antigens such
as invading bacteria, viruses, or damaged tissue. On receipt
of the so-called ‘‘danger signals’’ or in response to
proinflammatory cytokines or T-cell-derived signals such as
CD40 ligand (CD40 L), DCs mature and also undergo loss
of phagocytic capacity and upregulation of costimulatory
molecules, major histocompatibility complex class II, and
cytokines (Steinman, 2007). Most importantly, DCs acquire
the ability to migrate from peripheral tissues to the T-cell
areas of draining lymphoid organs. This is associated with the
expression of chemokine receptors resulting in a responsive-
ness to CCL21 and CCL19, and the expression of matrix-
degrading enzymes such as matrix metalloproteinases (MMP)
(Banchereau and Steinman, 1998); (Steinman et al., 1995).
Once in lymph nodes, they initiate immune responses by
activating T cells and controlling the differentiation of T cells
either to a TH1, TH2, or TH17 phenotype or to regulatory
T cells (Steinman, 2007).
In this process, DCs have to move through connective
tissues and cross basement membranes. MMP-9 is especially
important in migration, as it cleaves collagen IV, the
major component of basement membranes. The role of
MMP-9 in DC migration has been demonstrated in vitro,
in skin explant models, and in vivo after treatment with
anti-MMP-9 antibodies, as well as in MMP-9-deficient mice
(Yen et al., 2007). Thus, DCs from MMP-9-deficient mice
exhibit a significantly reduced emigration of Langerhans cells
(LCs) from skin explant culture models (Ratzinger et al.,
2002).
In addition to its matrix-degrading capacity, MMP-9 is also
involved in the processing of cytokines and chemokines
relevant for inflammation and migration (Opdenakker et al.,
2001a, 2001b). Furthermore, MMP-9 supported the migration
of DCs independent of an extracellular barrier (Hu and
Ivashkiv, 2006). Hu and Ivashkiv (2006) showed that MMP-9
enhanced the CCL5-mediated signaling by a synergistic
activation of JNK. Thus, MMP-9 may have an effect as a
tuner and amplifier of immune functions by cleavage of
matrix components and modification of cytokine and
chemokine activity (Opdenakker et al., 2001b).
It was demonstrated in recent years that the stromal
microenvironment is actively involved in the regulation of
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immune responses (Svensson and Kaye, 2006). Zhang et al.
(1998) described that splenic stromal cells drive DCs to
differentiate into a regulatory phenotype. Hyaluronic acid
and osteopontin regulate the differentiation and maturation of
DCs (Termeer et al., 2003; Renkl et al., 2005). Fibroblasts in
particular display a wide and varied biosynthetic repertoire,
including the production of matrix components, matrix-
degrading enzymes, cytokines, chemokines, and prostanoids
(Parsonage et al., 2003; Buckley et al., 2001, 2004). Thus, it is
likely that DCs receive information from the local environ-
ment. For example, the lack of matrix-associated SPARC
(secreted protein, acidic and rich in cysteine) in skin
increased the emigration of LCs from the skin to the lymph
node. In this process, a cutaneous contact hypersensitivity
reaction was enhanced (Sangaletti et al., 2005). Moreover,
the local microenvironment is involved in the regulation of
the organ-specific homing of T cells. Thus, subcutaneous
but not intraperitoneal application of DCs stimulated the
expression of skin-homing molecules on T cells, resulting in
an enhanced cutaneous contact hypersensitivity reaction
(Dudda et al., 2004). Recently, we showed that Thy-1
expressed in fibroblasts and activated endothelial cells
stimulated the secretion of MMP-9 from neutrophils, resulting
in an enhanced migration through extracellular matrix
(Saalbach et al., 2008). Thus, all the data support the fact
that immunocompetent cells receive functionally important
information from the local environment.
In this study, we demonstrate that activated fibroblasts
provided a microenvironment that directly and rapidly
enhanced the migratory capacity of DCs by stimulating their
MMP-9 secretion. IL-6 released from fibroblasts was identified
as an essential mediator in this process, in which fibroblasts
actively participate in the regulation of an immune response.
RESULTS
Activated human dermal fibroblasts stimulate the secretion of
MMP-9 from DCs
Upon activation, DCs mature and acquire the ability to migrate
through the extracellular matrix from peripheral tissues to the T-
cell areas of draining lymphoid organs. As MMP-9 is important
for the migration of DCs, we were interested to determine
whether dermal fibroblasts as cells of the dermal microenvir-
onment were able to regulate the expression and secretion of
MMP-9 from DCs. Fibroblasts were co-cultured with immature
DCs for 6hours to study their role in the regulation of MMP-9
release from DCs and their contribution to DC migration. DCs
were cultured without stimulus as control or were stimulated
with tumor necrosis factor (TNF)a/IL-1b or lipopolysaccharide
(LPS). As DC migration is required during steady-state
conditions in the absence of an inflammation, as well as
during an inflammatory reaction (Steinman, 2007), we used
resting fibroblasts and fibroblasts stimulated with TNFa and IL-
1b for 18hours to mimic an inflammatory microenvironment.
TNFa and IL-1b were chosen because they are highly
expressed in cutaneous inflammation (Taylor et al., 2004;
Aggarwal et al., 2006).
Immature DCs expressed only small amounts of MMP-9.
TNFa/IL-1b significantly stimulated MMP-9 secretion from
immature DCs. Interestingly, the initiation of DC maturation
by adding LPS did not significantly stimulate MMP-9
secretion within 6 hours (Figure 1a, b). Unstimulated fibro-
blasts did not enhance MMP-9 secretion from immature DCs.
Importantly, in the co-culture of DCs with TNFa/IL-1b-
stimulated fibroblasts, the mRNA expression and secretion of
MMP-9 in DCs were significantly increased compared with
that in immature DCs, as well as in DC stimulated with LPS or
TNFa/IL-1b (Figure 1a–c). Although the addition of TNFa and
IL-1b stimulated MMP-9 mRNA expression and secretion to
DCs alone, DCs in the co-culture with fibroblasts activated by
the same concentration of TNFa and IL-1b secreted
significantly more MMP-9 (Figure 1b and c).
As cell-free supernatants of TNFa/IL-1b-activated fibro-
blasts also stimulated MMP-9 secretion from immature DCs
in the same manner as did the direct co-culture, we
postulated that fibroblast-derived soluble mediators are
responsible for MMP-9 upregulation in DCs. Second, we
could assess that MMP-9 in the co-culture was derived from
DCs, as fibroblasts did not express MMP-9 (Figure 1b).
Next, we were interested in determining whether the
stimulation of MMP-9 secretion by activated fibroblasts is
dependent on the maturational state of DCs. Thus, we
compared immature DCs and fully matured DCs. Further-
more, in an attempt to imitate the situation of DCs at first
contact with pathogens and the subsequent initiation of DC
maturation, we preincubated DCs with LPS for 1 or 3 hours
(partially matured DCs).
Immature DCs, partially matured DCs, and LPS-matured
DCs were stimulated with supernatants of TNFa/IL-1b-
stimulated fibroblasts. In another panel, DCs were stimulated
simultaneously with supernatants of activated fibroblasts and
LPS. As shown in Figure 1d, soluble factors of activated
fibroblasts increased the secretion of MMP-9 from both
immature and partially matured DCs, and from DCs
stimulated simultanously with LPS and supernatants of
activated fibroblasts. In contrast, MMP-9 secretion from
mature DCs was not affected by soluble mediators from
activated fibroblasts.
To test whether results obtained with monocyte-derived
DCs are of general importance for DCs traveling from skin to
lymph nodes, we performed additional experiments using LCs.
LCs were generated in vitro by a differentiation of monocytes in
the presence of IL-4, GM-CSF, and TGFb. In addition, LCs were
isolated from human epidermis. Of the isolated LCs, 80–90%
expressed Langerin, confirming the LC phenotype (data not
shown). LCs were cultured with supernatants of TNFa/IL-1b-
stimulated fibroblasts or with TNFa/IL-1b as control. As shown
in Figure 1e, soluble factors of TNFa/IL-1b-stimulated fibro-
blasts enhanced MMP-9 secretion from both in vitro-generated
LCs as well as from LCs isolated from human epidermis.
Induction of DC maturation through toll-like receptors is not
mandatorily associated with the upregulation of MMP-9
secretion
In previous experiments, we observed that stimulation of DCs
with LPS that signals through toll-like receptor 4 (TLR4) did
not stimulate MMP-9 secretion. On the other hand, LPS is a
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potent inducer of DC maturation. Now, we were interested in
determining whether other pathogen-associated ligands
recognized by TLR could regulate the secretion of MMP-9.
Iwasaki and Medzhitov (2004) described the expression of
TLR1–4, TLR6, and TLR8 on in vitro-generated monocyte-
derived DCs. Therefore, we stimulated DCs with the
corresponding agonists. Stimulation of TLR by the indicated
agonists induced the maturation of DCs, which was shown by
an increased expression of costimulatory molecules (CD80,
CD83, and CD86) and MHC II. In Figure 2a, the expression of
CD86 is exemplarily shown. As monocyte-derived DCs did
not express TLR7, Imiquimod, a TLR7 agonist, was used as
negative control. Consequently, Imiquimod did not induce
the maturation of DCs. In spite of the induction of DC
maturation by TLR3-, TLR4-, and TLR8 activation, these
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Figure 2. TLR3-, TLR4, and TLR8 agonists induce maturation of dendritic
cells (DCs), but do not stimulate their MMP-9 secretion. Immature DCs were
stimulated with Pam3 (synthetic triacetylated lipoprotein; 0.5 mgml1), HKLM
(heat-killed preparation of Listeria monocytogenes, 106 cellsml1), polyI:C
(synthetic analog of double-stranded RNA; 10mgml1), LPS (0.5 mgml1),
FSL1 (synthetic diacetylated lipoprotein; 0.5 mgml1), Imiquimod (1 mgml1),
and ssRNA (single-stranded RNA 40; 1 mgml1). The TLR that was stimulated
by the appropriate agonist was noted. (a) DCs were stimulated for 24 hours.
CD86 expression was evaluated by flow cytometry. (b) Supernatants were
collected after 6 hours and MMP-9 secretion was detected by gelatine
zymography. Band intensity was detected by densitometric evaluation.
Unstimulated DCs were used as control and was set to 100%. The mean±SD
of three independent experiments is shown. *Po0.05 compared with that of
DCs (t-test).
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Figure 1. Tumor necrosis factor (TNF)a/IL-1b-treated human fibroblasts
stimulate matrix metalloproteinase-9 (MMP-9) secretion by dendritic cells
(DCs). (a) Monocyte-derived immature DCs were co-cultured with human
dermal fibroblasts or with TNFa/IL-1b-stimulated fibroblasts (FB[TNFa/IL-1b]) for
6hours. As control, DCs were cultured with 1mgml1 LPS, 5ngml1 TNFa/
2.5 ngml1 IL-1b, or without stimulus. One representative zymogram is shown
(b). Immature DCs were co-cultured with fibroblasts (FB), with TNFa/IL-1b-
stimulated fibroblasts (FB[TNFa/IL-1b]), or with supernatants (SN) of TNFa/IL-1b-
activated FB for 6hours. In parallel, DCs were cultured with 1mgml1 LPS;
5ngml1 TNFa/2.5ngml1 IL-1b; or without stimulus. Band intensity in gelatine
zymography was analyzed by densitometric evaluation. Unstimulated DCs were
used as control and were set to 100%. The mean±SD of five independent
experiments is shown. *Po0.05 compared with DCs; #Po0.05 compared with
DCsþTNFa/IL-1b (Mann–Whitney rank-sum test). (c) DCs were stimulated with
supernatants of TNFa/IL-1b-stimulated fibroblasts (SN FB[TNFa/IL-1b]).
As control, DCs were cultured with recombinant TNFa/IL-1b or without stimulus.
After 6hours, RNA was prepared and MMP-9 mRNA expression was detected by
quantitative real time–PCR. The mean±SD of three independent experiments is
shown. *Po0.05 compared with DCs; #Po0.05 compared with TNFa/IL-1b-
stimulated DC (Mann–Whitney rank-sum test). (d) Immature DCs (iDC), partially
mature (1hour or 3hours LPS maturation before stimulation, paDC) DCs or
mature DCs (mDC) were stimulated with supernatants of TNFa/IL-1b-stimulated
fibroblast. In addition, fibroblasts were stimulated simultaneously with
supernatants of TNFa/IL-1b-stimulated fibroblasts and LPS. MMP-9 secretion was
detected by gelatine zymography. Band intensity was analyzed by densitometric
evaluation. As control, DCs stimulated with TNFa/IL-1b with or without LPS
were used and were set to 100%. The mean±SD of three independent
experiments is shown. *Po0.05 compared with DCsþ TNFa/IL-1b
(Mann–Whitney rank-sum test). (e) In vitro generated LCs or LCs isolated from
human epidermis were incubated with supernatants of TNFa/IL-1b-stimulated
fibroblasts or TNFa/IL-1b as control. MMP-9 secretion was detected by gelatine
zymography. Band intensity was analyzed by densitometric evaluation. LC
stimulated with TNFa/IL-1b were used as control and were set to 100%. The
mean±SD of three independent experiments is shown. *Po0.05 compared with
DCsþTNFa/IL-1b (Mann–Whitney rank-sum test).
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agonists did not enhance the MMP-9 secretion detected by
gelatine zymography after 6 hours of stimulation (Figure 2b).
In contrast, the stimulation of DCs with agonists of TLR1/2
(Pam3) or TLR6/2 (FSL1) induced the maturation of DCs as
well as the stimulation of MMP-9 release. Thus, stimulation of
DCs through TLR induced the maturation of DCs, but this is
not necessarily associated with an upregulation of MMP-9
secretion.
Taken together, our data support the notion that, in
addition to ‘‘classical’’ DC maturation signals as mediated by
TLRs, supplementary signals from the tissue microenviron-
ment are required to induce a rapid release of MMP-9. In this
manner, the stromal fibroblast from the dermal microenvir-
onment might facilitate DC migration.
Fibroblast-derived IL-6 is involved in the stimulation of MMP-9
secretion from DCs on contact with fibroblasts
Next, we studied the mechanisms of fibroblast-stimulated
MMP-9 secretion. We speculated that fibroblast-derived
soluble factors were mainly responsible for upregulated
MMP-9 secretion, because cell-free supernatants of activated
fibroblasts stimulated MMP-9 secretion in a similar manner as
did the direct co-culture (Figure 1). As fibroblasts produce IL-
6 and prostaglandin E2 (PGE2) upon activation through
CD40, we verified the release of these mediators after
stimulation with TNFa/IL-1b (Smith et al., 1997a, 1997b;
Parsonage et al., 2003; Buckley et al., 2001, 2004). TNFa/IL-
1b-stimulated fibroblasts produced 3300±2300pgml1 of
IL-6 and 3200±1400pgml1 PGE2 (Figure 3a). To identify
which of these mediators were responsible for the increase of
MMP-9 secretion, DCs were stimulated for 6 hours with
0.1–10 ngml1 recombinant IL-6 or 3.5 ngml1 PGE2. In
addition, we used 352 ngml1 (106 M) PGE2, as this
concentration was reported to induce MMP-9 secretion
from DCs (Yen et al., 2007). As shown in Figure 3b, IL-6
was a potent inducer of MMP-9 secretion from DCs in
the concentration range found in supernatants of
activated fibroblasts. In contrast, PGE2 stimulated MMP-9
secretion only at high concentrations (352 ngml1 106M). At
a lower concentration (3.5 ngml1), as found in our
co-cultures, PGE2 was not able to increase MMP-9 secretion
from DCs.
As IL-6 was a potent inducer of MMP-9 in DCs, we studied
the role of IL-6 in the fibroblast-mediated stimulation of
MMP-9 secretion of DCs. Secretion of IL-6 by fibroblasts was
inhibited by small interfering RNA (siRNA) silencing.
Fibroblasts were transfected with IL-6 siRNA or as control
with scrambled siRNA. After transfection, fibroblasts were
stimulated with TNFa/IL-1b for 24 hours to induce IL-6
secretion. Efficiency of IL-6 silencing was determined by
the detection of IL-6 in supernatant using ELISA. We used two
separate IL-6 siRNAs. Both downregulated the IL-6 expression
(data not shown). The most effective siRNA was used in
subsequent experiments. As shown in Figure 4a and b,
silencing of IL-6 resulted in a significant decrease but not in a
complete inhibition of IL-6 secretion. Transfection with
scrambled siRNA did not significantly affect IL-6 secretion
compared with nontransfected fibroblasts.
Next, we tested whether IL-6 is the relevant fibroblast-
derived mediator that induces MMP-9 secretion from DCs. To
address this issue, DCs were stimulated with supernatants of
fibroblasts transfected with IL-6 siRNA or scrambled siRNA.
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Figure 3. IL-6 induces the secretion of matrix metalloproteinase-9 (MMP-9)
from dendritic cells (DCs). (a) Fibroblasts were cultured for 18 hours with
5 ngml1 tumor necrosis factor-a (TNFa) and 2.5 ngml1 IL-1b, or in serum-
free medium. IL-6 and prostaglandin E2 (PGE2) were measured in the
supernatant by ELISA. (b) DCs were stimulated with indicated concentrations
of IL-6 or PGE2 for 6 hours. As control, DCs were cultured without
stimulation. MMP-9 was detected in the supernatant by gelatine zymography.
Band intensity was detected by densitometric evaluation. MMP-9 secretion
from unstimulated DCs was set to 100%. The mean±SD of three independent
experiments is shown. *Po0.05 compared with that of DCs (t-test).
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Figure 4. Small interfering RNA (siRNA) silencing of IL-6 resulted in
downregulation of IL-6 from activated fibroblasts. Fibroblasts were
transfected with IL-6 siRNA or scrambled (scr) siRNA. As control, untreated
fibroblasts were used. After 24 hours, transfected fibroblasts were stimulated
with tumor necrosis factor-a (TNFa)/IL-1b. IL-6 was detected in the
supernatants after 24 hours by ELISA. The mean±SD of five independent
experiments is shown.*Po0.05 compared with that of dendritic cells (t-test).
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As control, DCs were stimulated either with TNFa/IL-1b or
with supernatants of TNFa/IL-1b-activated fibroblasts. Again,
the incubation of DCs with supernatants of TNFa/IL-1b-
activated fibroblasts clearly enhanced MMP-9 secretion from
DCs compared with DCs stimulated with TNFa/IL-1b
(Figure 5). It is noteworthy that the inhibition of IL-6 secretion
from TNFa/IL-1b-activated fibroblasts resulted in a significant
decrease in MMP-9 release from DCs. Transfection with
scrambled siRNA did not affect MMP-9 secretion (Figure 5).
To confirm these results in another experimental system,
murine DCs were co-cultured with fibroblasts from IL-6-
deficient mice or wild-type mice. Wild-type fibroblasts
secreted low levels of IL-6 (32±10 pgml1). In contrast to
human unstimulated fibroblasts, IL-6 was already clearly
upregulated in the co-culture of DCs and unstimulated wild-
type fibroblasts (754±254pgml1). In contrast, fibroblasts
from IL-6-deficient mice did not produce IL-6. In the co-
culture of IL-6-deficient fibroblasts with DCs, only small
amounts of IL-6 were detectable (109±54 pgml1) (Figure
6a). Consequently, fibroblasts from IL-6/ mice stimulated
MMP-9 secretion in DCs to a significantly smaller extent than
did fibroblasts from wild-type controls (Figure 6b).
Taken together, our data underline the fact that fibroblast-
derived IL-6 was involved in the regulation of fibroblast-
stimulated MMP-9 secretion from DCs.
Activated human dermal fibroblasts stimulate the migratory
capacity of DCs depending on MMP-9
As MMP-9 is important for the migration of DCs through
basement membranes, we studied the functional relevance of
fibroblast-stimulated MMP-9 secretion in DCs in migration
assays through matrigel, a basement membrane-like struc-
ture. DCs were incubated with activated fibroblasts for
2 hours. As control, DCs stimulated with TNFa/IL-1b were
used. DCs (5105) were seeded in the upper chamber of
matrigel inserts and a medium with 1% serum was used as a
chemoattractant in the lower chamber. Migrated cells were
counted by flow cytometry after 24 hours. In line with their
enhanced MMP-9 secretion, fibroblast-stimulated DCs mi-
grated significantly more than TNFa/IL-1b-stimulated DCs
(Figure 7a). To investigate whether fibroblast-stimulated
MMP-9 secretion by DCs is involved in enhanced DC
transmigration, MMP-9 activity was blocked. As shown in
Figure 7b, the addition of function-blocking anti-MMP-9
antibodies significantly inhibited the fibroblast-stimulated
transmigration of DCs.
In addition, DCs were stimulated with supernatants of
TNFa/IL-1b-stimulated fibroblasts in which IL-6 secretion had
been inhibited by siRNA silencing. As a result of IL-6
silencing in fibroblasts, MMP-9 secretion (Figure 5) and the
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Figure 6. Murine fibroblasts stimulate MMP-9 secretion from murine bone
marrow-derived dendritic cell (DC) through IL-6 secretion. Murine bone
marrow-derived DCs (WT-DCs) from BALB/c mice were co-cultured with
fibroblasts from IL-6/ mice (IL-6-KO-FB) or from wild-type controls (WT-
FB). As control, DCs or fibroblasts were cultured alone. Supernatants were
collected after 6 hours. (a) Murine IL-6 was detected by ELISA. *Po0.05
compared with that of WT-FB and WT-DCsþ IL-6-KO-FB (Mann–Whitney
rank-sum test). (b) MMP-9 secretion was detected by gelatine zymography.
Band intensity was analyzed by densitometric evaluation. Data represent the
mean±SD of five independent experiments. *Po0.05 compared with that of
WT-DCs and WT-DCsþ IL-6-KO-FB (Mann–Whitney rank-sum test).
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Figure 5. The knockdown of IL-6 expression by siRNA silencing in fibroblasts
results in a significant decrease in fibroblast-stimulated MMP-9 secretion
from DCs. DCs were stimulated with supernatants of tumor necrosis factor-a
(TNFa)/IL-1b-stimulated fibroblasts transfected with IL-6 siRNA or scrambled
(scr) siRNA, respectively. As control, DCs were incubated with TNFa/IL-1b or
with supernatants of TNFa/IL-1b-stimulated fibroblasts (FBa). Supernatants
were collected after 6 hours and MMP-9 release was detected by gelatine
zymography. Band intensity was analyzed by densitometric evaluation.
MMP-9 secretion of DCs stimulated with supernatant from TNFa/IL-1b-
stimulated fibroblasts was set to 100%. Data represent the mean±SD of five
independent experiments. *Po0.05 compared with that of DCsþ FBa
(Mann–Whitney rank-sum test).
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migratory capacity of DCs were reduced (Figure 7c).
Similarly, MMP-9 secretion of murine DCs on co-culture
with fibroblasts from IL-6-deficient mice compared with that
on co-culture with wild-type fibroblasts also resulted in a
decreased DC migration through the matrigel (Figure 7d).
DISCUSSION
In this study, we demonstrate how stromal fibroblasts from
the microenvironment of the skin support the migration of
DCs and thus have the potential to orchestrate immune
responses in skin.
Dendritic cell migration is regulated by many factors. For
example, the proinflammatory cytokines, TNFa and IL-1b,
can initiate the migration of DCs (van Helden et al., 2006).
Chemokines such as CXCL12 (SDF-1), CCL-20, CCL19, and
CCL21 were shown to enhance the emigration of LCs and
dermal DCs from skin (Adema et al., 2005; Ouwehand et al.,
2008). Interactions with the extracellular matrix through
CD44 or integrins are important for the migration of DCs
(Price et al., 1997; Weiss et al., 1997). Finally, proteases
degrade the extracellular matrix and thus are critically
involved in the regulation of cell migration. Specifically,
Ratzinger et al. (2002) demonstrated that MMP-2 and MMP-9
are essential for the emigration of LCs from epidermal skin
explants, as well as for the emigration of dermal DCs from the
dermis. The importance of MMP-9 in the emigration of DCs
from epidermis and dermis was shown by function-blocking
antibodies, MMP inhibitors, and MMP-9-deficient mice
(Ratzinger et al., 2002; Yen et al., 2007).
Stromal cells are connective tissue cells forming and
organizing the local stromal microenvironment. They have
important functions in tissue development and homeostasis
such as in coordinating matrix remodeling, in the deposition
of ECM components, in tissue scaffolding, and in the
regulation of cellular migration (Svensson and Kaye, 2006).
Fibroblasts display a wide and variable biosynthetic reper-
toire, including the production of matrix components, matrix-
degrading enzymes, cytokines, chemokines, and prostanoids
(Buckley et al., 2001, 2004; Parsonage et al., 2003, 2004).
On the basis of these data, we were interested in
determining whether fibroblasts regulate the migration of
DCs through the stimulation of MMP-9 secretion. As DC
migration is essential during both steady-state conditions in
the absence of inflammation, as well as during inflammation,
DCs were co-cultured either with resting fibroblasts or with
fibroblasts stimulated with TNFa and IL-1b to mimic a
proinflammatory tissue microenvironment. TNFa and IL-1b
were chosen as stimuli, as they are highly expressed during
cutaneous inflammation (Taylor et al., 2004; Aggarwal et al.,
2006). Resting fibroblasts did not significantly enhance the
secretion of MMP-9 from immature DCs. In contrast,
fibroblasts stimulated by TNFa and IL-1b clearly increased
the secretion of MMP-9 from DCs. Specifically, MMP-9
transcription was induced in DCs on interaction with TNFa/
IL-1b-stimulated fibroblasts, as shown by quantitative real-
time–PCR. To exclude that this effect was merely due to
TNFa/IL-1b, DCs were stimulated with the same concentra-
tions of TNFa/IL-1b in the absence of fibroblasts. It is
noteworthy that co-culture of DCs with TNFa/IL-1b-stimu-
lated fibroblasts significantly enhanced MMP-9 secretion up
to 10-fold more than that with TNFa/IL-1b alone. As cell-free
supernatants of TNFa/IL-1b-treated fibroblasts stimulated
MMP-9 secretion in a manner similar to the direct DCs–
fibroblast interaction, soluble fibroblast-derived factors had to
be responsible.
Several reports described the importance of MMP-9 in the
migration of DCs (Ratzinger et al., 2002; Yen et al., 2007).
Indeed, we demonstrate in this study that enhanced MMP-9
secretion of fibroblast-stimulated DCs resulted in an
increased transmigration through basement membrane-like
structures. A decrease in this enhanced transmigration by
anti-MMP-9 antibodies proved the important role of MMP-9
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Figure 7. Tumor necrosis factor-a (TNFa)/IL-1b-stimulated fibroblasts
enhanced the migration of dendritic cells (DCs) through matrigel. DCs were
co-cultured with TNFa/IL-1b-stimulated fibroblasts (FBa) for 2 hours.
Subsequently, DC migration through matrigel inserts was measured after
24 hours. Migrated cells were counted by flow cytometry. Data represent the
mean±SD of at least four independent experiments. *Po0.05
(Mann–Whitney rank-sum test). (a) Migration of DCs stimulated with
5 ngml1 TNFa/2.5 ngml1 IL-1b and DCs on co-culture with TNFa/IL-1b-
stimulated fibroblasts (FBa) was detected. Migration of TNFa/IL-1b-stimulated
DCs was set to 100%. (b) DCs on co-culture with TNFa/IL-1b-stimulated
fibroblasts (FBa) were added to the upper part of the transmigration chamber
in the presence of an anti-MMP-9 antibody or an isotype control antibody (ctr
ab). DCs stimulated with TNFa/IL-1b were used as control. Migration in the
presence of the ctr ab was set to 100%. (c) Migration of DCs on culture with
supernatants of TNFa/IL-1b-stimulated fibroblasts (FBa) after IL-6 small
interfering RNA (siRNA) or scrambled (scr) siRNA transfection was detected.
DCs stimulated with TNFa/IL-1b were used as control. Migration on
stimulation with scr-transfected fibroblast supernatants was set to 100%.
(d) DCs from wild-type mice (WT-DCs) were collected after co-culture with
wild-type fibroblasts (WT-FB) or with fibroblasts from IL-6-deficient mice (IL-
6-KO-FB) and were added to the upper chamber of matrigel transwell inserts.
Migration on co-culture with WT-FB was set to 100%. Data represent the
mean±SD of at least three independent experiments. *Po0.05
(Mann–Whitney rank-sum test).
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in the stimulation of DC migration by fibroblasts. However,
MMP-9 antibodies did not completely block migration,
which may be because of residual MMP-9 or a contribution
of other yet unidentified MMPs. However, MMP-2 was not
secreted by DCs (data not shown). In aggregate, our data
demonstrate that MMP-9 released from DCs that had been
activated by TNFa/IL-1b-stimulated fibroblasts is at least in
part responsible for the enhanced migratory potential of
fibroblast-stimulated DCs.
To study the potential role of fibroblast-stimulated MMP-9
secretion in DCs during the initial phases of infection/
inflammation, we attempted to mimic the situation when
DCs first encounter antigens or pathogens and the subsequent
initiation of DC maturation and migration to lymph vessels. A
partial maturation was induced in DCs by 1–3 hours of
preincubation with LPS. Fibroblast-derived soluble factors
stimulated MMP-9 secretion from immature and partially
matured DCs (but importantly not from fully matured DCs),
supporting the hypothesis that signals from dermal fibroblasts
are especially important during the initial phase of antigen/
pathogen contact of DCs for stimulating DC migration. In
contrast, fully matured DCs, serving as a model for DCs that
have reached the regional lymph node, are no longer
susceptible to signals from dermal fibroblasts stimulating
their migration.
In our previous studies, we demonstrated that DCs
matured on interaction with tissue cultured fibroblasts
(Saalbach et al., 2007). At that time, we postulated that, on
culture, fibroblasts were activated, enabling them to induce
DC maturation. In this study, we optimized the isolation
technique of primary fibroblasts by a dramatic reduction in
culture time, which resulted in resting fibroblasts as shown by
an extremely low release of IL-6, IL-8, PGE2, a low level
expression of ICAM-1, and their inability to induce DC
maturation (Figure 3, data not shown). These resting
fibroblasts failed to induce MMP-9 release from DCs,
whereas fibroblasts primed by TNFa and IL-1b markedly
stimulate MMP-9 secretion and DC migration. It should also
be noted that human fibroblasts activated by TNFa and IL-1b
did not induce phenotypic maturation of DCs (data not
shown). We speculate that short-term TNFa/IL-1b treatment
results in different activation patterns of fibroblasts compared
with long-term tissue culture.
We were interested in the mechanisms by which TNFa/
IL-1b-treated fibroblasts stimulate MMP-9 secretion in DCs
and subsequently enhance DC migration. Recently, we
showed that the direct interaction of neutrophils with
fibroblasts through Thy-1/Mac-1 is required to stimulate
the release of MMP-9 from neutrophils (Saalbach et al.,
2008). TGFb, TNFa, bFGF, and IL-1b upregulated MMP-9
secretion in fibroblasts. In T cells, IL-2, IL-4, and TNFa
stimulated MMP-9 secretion (Kossakowska et al., 1999).
Thus, in different cell types, divergent mechanisms of the
regulation of MMP-9 expression are used (Kossakowska et al.,
1999).
To identify the fibroblast-derived soluble factor respon-
sible for MMP-9 release in DCs, we analyzed the cytokine
production of TNFa/IL-1b-stimulated fibroblasts. TNFa and
IL-1b, which are known inducers of MMP-9, cannot be
produced by fibroblasts (Bartholome et al., 2001, data not
shown). CCL5 has also been described to stimulate the
secretion of MMP-9 by DCs (Chabot et al., 2006), but
fibroblasts do not express CCL5 (data not shown). However,
TNFa/IL-1b-stimulated fibroblasts produced high levels of IL-
6 and PGE2. These factors are expressed in high levels at sites
of inflammation wherein DC migration takes place (Pease
and Sabroe, 2002; Park and Pillinger, 2007). Furthermore, we
demonstrated that recombinant IL-6, as well as PGE2, was
capable of increasing MMP-9 release from DCs.
Yen et al. (2007) showed that PGE2 enhanced MMP-9
secretion from DCs and subsequently stimulated the migra-
tion of DCs. However, PGE2 in concentrations found in the
supernatant of activated fibroblasts failed to induce MMP-9
release from DCs. However, when DCs were stimulated with
a 100-fold higher concentration of PGE2, as used by Yen
et al. (2007), an increased secretion of MMP-9 from DCs was
observed. Thus, PGE2 stimulates MMP-9 secretion by DCs;
however, the PGE2 concentrations produced by activated
fibroblasts in our system are too low to initiate this effect.
Although we cannot exclude that exogenously added PGE2 is
as efficient as PGE2 produced by fibroblasts, we consider it
unlikely that in our model, PGE2 is the factor responsible for
the stimulation of MMP-9 secretion from DCs on contact with
fibroblasts.
Fibroblasts produce high amounts of IL-6 on activation
(Park and Pillinger, 2007). IL-6 is elevated at sites of
inflammation such as in the synovial fluid of rheumatoid
arthritis patients (Alonzi et al., 1998; Boe et al., 1999). The
role of IL-6 in inflammation was shown in IL-6-deficient mice
that were not susceptible to antigen-induced arthritis (Alonzi
et al., 1998; Boe et al., 1999). Taken together, IL-6 seems to
be important for the development and maintenance of
rheumatoid arthritis; however, little is known with regard to
its role in cutaneous inflammation. IL-6 is involved in the
regulation of T- and B-cell responses, in neutrophil activation
and mobilization, and in the activation of monocytes/
macrophages. It activates endothelial cells to produce
chemokines, thus indirectly regulating the recruitment of
leukocytes, inducing synovial fibroblast proliferation and
osteoklast formation. However, to the best or our knowledge,
there are no data showing the involvement of IL-6 in the
control of DC migration.
Decrease in MMP-9 secretion on co-culture of DCs with
TNFa/IL-1b-stimulated human fibroblasts after knock down of
IL-6 expression by siRNA confirms the role of IL-6 in the
regulation of MMP-9 secretion from DCs, and thus in the
migration of DCs. Moreover, recombinant IL-6 dose depen-
dently enhanced MMP-9 secretion. In addition, unstimulated
human fibroblasts—which did not produce IL-6—also failed
to stimulate MMP-9 secretion from DCs. The relevance of
IL-6 in the regulation of MMP-9 secretion from DCs was
documented in a second experimental model. Fibroblasts
from IL-6-deficient mice also failed to enhance MMP-9
secretion from bone marrow-derived wild-type mouse DCs.
In contrast to human fibroblasts, murine-unstimulated fibro-
blasts already secreted IL-6 on co-culture with DCs. In
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aggregate, both in mice and men, MMP-9 release from DCs
was dependent on the release of IL-6 from fibroblasts. The
role of IL-6 in the regulation of MMP-9 and migration was
shown in a few other nonhematopoietic cell types, such as
cerebral endothelial cells or glial cells (Yao et al., 2006; Lin
et al., 2007). In malignant non-Hodgkin’s lymphomas, the
IL-6 expression correlated with MMP-9 mRNA expression
(Kossakowska et al., 1999). Furthermore, IL-6 stimulated
MMP-9 secretion in Raji and Jurkat cells (Kossakowska et al.,
1999).
To our knowledge, it is previously unreported that
fibroblast-derived IL-6 is an inducer of MMP-9 in DCs and
thus has an important role in the regulation of DC migration.
Besides its role in inflammation, this mechanism might
contribute to the successful induction of antitumour
responses by DCs matured with a cocktail of TNFa, IL-1b,
PGE2, and IL-6 (McIlroy and Gregoire, 2003). Knockdown
experiments clearly support our hypothesis on the role of IL-6
in the induction of MMP-9 release from DCs. Here, we have
to consider that siRNA silencing did not result in a complete
inhibition of MMP-9 secretion or migration. Thus, the data
cannot exclude the involvement of yet other still unknown
factors involved in the stimulation of MMP-9 secretion from
DCs on interaction with activated fibroblasts.
Our data demonstrated that TNFa/IL-1b-stimulated fibro-
blasts provided a microenvironment that directly and rapidly
stimulated MMP-9 secretion by DCs. In this manner, TNFa/
IL-1b-stimulated fibroblasts directly supported the migration
of DCs, which is essential to initiate an immune response.
However, keratinocytes, endothelial cells, or nonresident
leukocytes might also support DC migration, for example,
through the release of prostaglandins or chemokines such as
CCL5 (Chabot et al., 2006). Moreover, other local factors
such as retinoic acid or hypoxia may contribute, as they were
described to regulate MMP-9 secretion from DCs (Darmanin
et al., 2007; Zhao et al., 2008).
In our study, we used monocyte-derived DCs as a model
for DC. To further validate the fact that the stimulation of
MMP-9 secretion by activated fibroblasts represents a general
mechanism, we also investigated LCs. Indeed, fibroblast-
derived soluble factors also upregulated MMP-9 secretion
from in vitro-generated LCs, as well as from LCs isolated from
human epidermis. Especially for LC, the regulation of LC
migration by fibroblast-derived mediators was shown. Ouwe-
hand et al. showed that CXCL12 produced by stromal
fibroblasts has an important role in the migration of LCs from
the epidermis to the dermis (Ouwehand et al., 2008). In this
study, we also show that fibroblast-derived IL-6 also affects
LC migration by the regulation of MMP-9 secretion.
Interestingly, maturation of DCs that often involves TLRs
was not necessarily associated with rapid MMP-9 release
by DCs. Stimulation through TLR-3, TLR-4, and TLR-8 —
although inducing phenotypic DC maturation — did not
induce an immediate MMP-9 release from DCs. In contrast,
TLR2 stimulation enhanced MMP-9 secretion. There are
several reports showing that different TLR agonists exhibit
different effects on the secretion of MMPs, cytokines, and
chemokines from DC (Ketloy et al., 2008; Zhang et al., 2008;
Bansal et al., 2009; Makela et al., 2009). Our results are also
in line with data of Bartholome et al. (2001) who showed the
stimulation of MMP-9 secretion from DCs by TNFa and IL-1b,
whereas LPS failed to augment MMP-9 release. In addition,
van Helden et al. (2006) demonstrated that TNFa and PGE2
induced a fast transition from an adhesive to a highly
migratory DC phenotype, whereas LPS stimulated migration
through the induction of PGE2, which in turn stimulated the
migration of DCs with a long lag phase. Similar mechanisms
may account for our observation that LPS was unable to
induce immediate MMP-9 secretion from DCs. In detail,
immature DCs do not secrete IL-6, by contrast activated
fibroblasts secrete large amounts of IL-6. This fibroblast-
derived IL-6 induced an immediate release of MMP-9
from immature or partially matured DCs. By contrast, LPS
was not capable of directly stimulating this rapid MMP-9
release in immature DCs. However, LPS is capable of
inducing the transcription and subsequent secretion of IL-6
in DC at later stages (Macagno et al., 2007, data not shown).
Thus, it seems plausible that at later stages of LPS-induced
maturation, autocrine-produced IL-6 stimulates MMP-9
release from DCs. Thus, immature and partially mature
DCs, which serve as a model of DC within skin en route to
the draining lymph nodes, require fibroblast-derived IL-6 for
immediate MMP-9 secretion. Fully matured DCs, serving
as a model for DC within the draining lymph node,
secrete IL-6 and are thus independent of fibroblast-derived
IL-6 for the regulation of MMP-9 secretion. This notion is
supported by our observation that fibroblast-derived soluble
factors stimulated MMP-9 secretion in immature or partially
mature DCs, but could not augment MMP-9 release from
mature DCs.
On the basis of our data, we hypothesize that efficient DC
migration may require a stimulation by both antigenic/
pathogenic stimuli, as well as by local factors provided by a
proinflammatory tissue microenvironment. On the one hand,
activation of DCs by pathogenic stimuli such as TLR agonists is
essential to induce the expression of costimulatory molecules
and cytokines, which enable DCs to activate T cells and thus to
initiate an adequate immune response. On the other hand, the
proinflammatory tissue microenvironment through TNFa and
IL-1b, produced by resident and nonresident cells such as
monocytes, keratinocytes, or endothelial cells (Aggarwal et al.,
2006), activates resident stromal cells such as fibroblasts,
resulting in the production of additional proinflammatory
mediators such as IL-6 and PGE2, which in turn can support
the migration of DCs through the enhanced release of MMP-9
and may thus serve as an amplifier during the initiation phase
of cutaneous immune responses.
MATERIALS AND METHODS
Reagents and antibodies
Anti-CD83-FITC, anti-CD86-FITC, and anti-CD80-FITC were purchased
from Becton Dickenson (Heidelberg, Germany). The anti-MMP-9
antibody (clone GE-213) was purchased from Millipore (Schwalbach,
Germany). Toll-like-receptor agonists were purchased from InvivoGen
(San Diego, CA). IL-6 was obtained from R&D (Wiesbaden, Germany)
and PGE2 from Sigma (Deisenhofen, Germany).
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Mice
BALB/c mice (6–8-weeks old) were used to obtain bone marrow-
derived DCs or dermal fibroblasts. The generation of IL-6-deficient
mice has been described previously (Kopf et al., 1994). The local
committee approved all described experiments (T62/07; T10/08).
Cell preparation and culture conditions
Human DCs. Peripheral blood mononuclear cells were isolated
using an endotoxin-free Ficoll–Paque gradient (Amersham Bios-
ciences; Uppsala, Sweden). CD14-positive monocytes were purified
using anti-CD14 magnetic beads (Miltenyi, Auburn, CA) according
to the manufacturer’s protocol. DCs were generated by culture of
1 106/ml CD14-positive cells for 4 days in DCs-RPMI (RPMI 1640
(Invitrogen, Karlsruhe, Germany) supplemented with 2% fetal calf
serum (FCS, Promocell, Heidelberg, Germany), 1% penicillin/
streptomycin (Invitrogen), 1% L-glutamine (Invitrogen), 0.1mM
nonessential amino acids (Invitrogen), 10mM HEPES (Invitrogen),
100Uml1 IL-4 (Peprotech, London UK), and 1000Uml1 GM-CSF
(Leukine, Berlex, Richmond, VA). The quality of DC preparations
with an immature phenotype was controlled by morphological
analysis and by verification of a high expression of CD1a and
CD11c. Furthermore, immature DCs did not express CD83 and
displayed only a low expression of CD86, CD80, and HLA-DR.
Langerhans cells. Langerhans cells were generated either by
culture of 1 106/ml CD14-positive cells for 4 days in DCs-RPMI
(RPMI 1640 (Invitrogen) supplemented with 2% FCS (Promocell), 1%
penicillin/streptomycin (Invitrogen), 1% L-glutamine (Invitrogen),
0.1mM nonessential amino acids (Invitrogen), 10mM HEPES
(Invitrogen), 100Uml1 IL-4 (Peprotech), 1000Uml1 GM-CSF
(Leukine, Berlex), and 10 ngml1 TGFb (R&D).
In addition, LCs were isolated from human epidermis. Human
skin was incubated with 2.2Uml1 dispase II (Roche, Mannheim,
Germany) for 18 hours at 4 1C. The epidermis was separated from the
dermis and digested with 0.05% trypsin (Biochrom, Berlin Germany)
and 0.1% DNase (Roche). Death cells were removed by Ficoll
density gradient centrifugation.
CD1a-positive cells were isolated by magnetic sorting using anti-
CD1a magnetic beads (Miltenyi) according to manufacturer’s
protocol. Of the isolated cells, 80–90% expressed langerin,
confirming the LC phenotype (data not shown).
Murine DCs. Bone marrow cells were isolated from the femur and
tibia of BALB/c mice (Lappin et al., 1999). Cells were cultured for
6 days in DCs-RPMI (RPMI 1640 (Invitrogen) supplemented with
10% FCS (Promocell), 1% penicillin/streptomycin (Invitrogen), 1%
L-glutamine (Invitrogen), 0.1mM nonessential amino acids (Invitro-
gen), 10mM HEPES (Invitrogen), 25Uml1 murine IL-4 (Peprotech),
and 400Uml1 murine GM-CSF (Peprotech). Subsequently, the
cells were harvested and CD11c-positive cells were purified
using anti-CD11c magnetic beads (Miltenyi) according to the
manufacturer’s protocol.
Primary fibroblasts. Human or murine skin biopsies were
incubated with 2.2Uml1 dispase II (Roche). Epidermal sheets were
removed and the dermal compartment was digested with
2.5mgml1 collagenase (Sigma) for 45minutes at 37 1C. Cell
suspension was passed through a 70 mm filter to remove tissue
debris. Cells were cultured at 37 1C, 5% CO2 in DMEM medium
(Biochrom) containing 10% FCS (Biochrom) and 1% penicillin/
streptomycin (Biochrom). After reaching confluence, cells were
passaged using 0.05% trypsin and 0.02% EDTA (Biochrom).
Fibroblasts were identified by morphological analysis and by a high
expression of Thy-1 (Saalbach et al., 1996, 1998).
Flow cytometry analysis
Cells were harvested and washed twice in phosphate-buffered
saline. Cells (2 105) were incubated with the indicated labeled
antibody for 60minutes at 4 1C. After washing twice with phosphate-
buffered saline/Gelafusal (Serumwerke Bernburg, Germany)/sodium
acid, antibody binding was analyzed by flow cytometry (FC 500,
Beckman Coulter, Krefeld, Germany).
Co-culture experiments
Dermal fibroblasts were cultured in 24-well plates until confluence
was reached. Fibroblasts were then washed carefully to remove
serum. For activation, fibroblasts were stimulated with 5 ngml1
TNFa and 2.5 ngml1 IL-1b (Peprotech) in RPMI 1640 medium
without serum for 18 hours. Subsequently, half of the medium was
replaced by a medium containing 4 105 DCs. As control, DCs and
fibroblasts alone were cultured under the same conditions. After
indicated times, either supernatants or cells were collected. In
mouse experiments, syngeneic DCs, and in human cocultures,
allogeneic DCs, were used.
Measuring MMP-9 release by gelatine zymography
Matrix metalloproteinase-9 was detected by gelatine zymography. The
method identifies active and inactive enzymes by the degradation of
gelatine within acrylamide gels. Cell-free supernatants were concen-
trated 10-fold by ultrafiltration using vivaspin 500 columns (Sartorius,
Go¨ttingen, Germany). Samples were diluted in a sample buffer (0.05M
Tris-HCl, pH 6.8, 0.4% saccharose, 1% SDS and 0.1% bromphenol
blue), applied to a 10% SDS-gel containing 1mgml1 gelatine,
and were electrophoretically separated. After electrophoresis,
gels were washed in 2.5% Triton X-100 for 30minutes and were
incubated overnight at room temperature in a development buffer
containing 0.05M Tris-HCl, pH 8.08mM CaCl2. Gelatine digestion was
visualized as white bands in the gel after staining with 0.25 %
Coomassie blue R250 and clearing with 10% acetic acid. MMP-9
activity was quantified by densitometric measuring (Intas, Go¨ttingen,
Germany). The absolute integrated area under the peak was
determined.
RNA preparation and real-time–PCR
Total RNA was prepared using the innuPREP RNA Mini Kit
(Analytikjena, Jena, Germany). The quantity and quality of RNA
were determined by spectrophotometry (ND-1000, NanoDrop
Technologies, Wilmington, DE). Total RNA of 1mg from each
sample was used for first-strand cDNA synthesis using M-MLV
Reverse Transcriptase (Promega, Madison, WI), following
the manufacturer’s instructions. Real-time–PCR was monitored by
EvaGreen fluorescence (Biotium, Hayward, CA) using GenTherm
DNA-Polymerase (Rapidozym, Berlin, Germany) with 2.5mM
MgCl2, 0.5mM Primer, 250mM dNTPs, and 0.5U polymerase per
reaction (20 ml) under primer-specific conditions. The following
experimental protocol for PCR reaction (40 cycles) was performed
452 Journal of Investigative Dermatology (2010), Volume 130
A Saalbach et al.
Dermal Fibroblasts Promote the Migration of DCs
on a Rotor-Gene 3000 cycler (Corbett Research, Sydney, Australia):
denaturation for 5minutes at 95 1C, followed by 40 amplification
cycles at 95 1C (10 second), annealing under primer-specific
conditions (20 seconds), and extension for 45 seconds at 72 1C.
Fluorescence was measured for 15 seconds at 80–85 1C depending
on the melting temperature of the specific PCR product. Primers with
the following sequences were chosen: rps-26: forward: 50-GGCTG
TAGTCCTGCCAGAAG-30, reverse: 50-TTCACATACAGCTTGGGAAG
CA-30, Tanneal¼ 61 1C; MMP-9 forward: 50-GCTATGGTTACACTCGG
GTG-30, reverse: 50-GCCATCTGCGTTTCCAAACC-30, Tanneal¼ 58 1C.
To confirm the specificity of the amplified DNA, a melting curve
was determined at the end of each run. Genes were normalized to the
unregulated housekeeping gene, rps-26, and results were expressed as
the ratio between target gene and rps-26 expression (arbitrary units).
Transfection of fibroblasts with siRNA
Small interfering RNA (Stealth Select RNAi) specific for human IL-6,
as well as scrambled siRNA (Stealth RNAi Negative Control (High
GC)), was purchased from Invitrogen. Subconfluent fibroblasts were
transfected with either 50 nM of IL-6-specific siRNA or scrambled
control siRNA using Lipofectamine RNAiMax Transfection Reagent
(Invitrogen) for 6 hours according to the manufacturer’s instructions.
Protein levels of IL-6 were detected after 18 hours by ELISA.
Invasion assay
Dendritic cells were co-cultured with TNFa/IL-1b-stimulated fibro-
blasts for 2 hours. As control, DCs were stimulated with 5 ngml1
TNFa and 2.5 ngml1 IL-1b. DCs (5 105) were added to the upper
chamber of 24-well transwell inserts coated with matrigel (BD
Biosciences, Heidelberg, Germany). For blocking MMP-9, anti-
MMP-9 antibody (1mgml1) was added to the upper chamber of the
transwell inserts. RPMI 1640 medium with 1% FCS was added to the
lower chamber as a chemoattractant. DCs were allowed to migrate
for 24 hours through matrigel. Migrated cells were counted by flow
cytometry (FC 500, Beckman Coulter).
ELISA
Murine IL-6 was measured using a commercially available ELISA kit
(eBioscience, Frankfurt; Germany). Human IL-6 was detected by
ELISA (BD, Heidelberg, Germany). PGE2 was measured by ELISA
purchased from R&D. Experiments were performed according to the
manufacturer’s instructions.
Statistical analysis
Data were analyzed using the Mann–Whitney rank-sum test or the t-
test depending on the normality of data. Values of P less than 0.05
were considered to be significant.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
We gratefully acknowledge H Gedicke and A Rohmer for their excellent
technical assistance.
REFERENCES
Adema GJ, de V I, Punt CJ, Figdor CG (2005) Migration of dendritic cell based
cancer vaccines: in vivo veritas? Curr Opin Immunol 17:170–4
Aggarwal BB, Shishodia S, Takada Y, Jackson-Bernitsas D, Ahn KS, Sethi G
et al. (2006) TNF blockade: an inflammatory issue. Ernst Schering Res
Found Workshop 56:161–86
Alonzi T, Fattori E, Lazzaro D, Costa P, Probert L, Kollias G et al. (1998)
Interleukin 6 is required for the development of collagen-induced
arthritis. J Exp Med 187:461–8
Banchereau J, Steinman RM (1998) Dendritic cells the control of immunity.
Nature 392:245–52
Bansal K, Kapoor N, Narayana Y, Puzo G, Gilleron M, Balaji KN (2009) PIM2
Induced COX-2 and MMP-9 expression in macrophages requires PI3K
and Notch1 signaling. PLoS One 4:e4911
Bartholome EJ, Van AI, Koyen E, Kiss R, Willems F, Goldman M et al. (2001)
Human monocyte-derived dendritic cells produce bioactive gelatinase
B: inhibition by IFN-beta. J Interferon Cytokine Res 21:495–501
Boe A, Baiocchi M, Carbonatto M, Papoian R, Serlupi-Crescenzi O (1999)
Interleukin 6 knock-out mice are resistant to antigen-induced
experimental arthritis. Cytokine 11:1057–64
Buckley CD, Filer A, Haworth O, Parsonage G, Salmon M (2004) Defining a
role for fibroblasts in the persistence of chronic inflammatory joint
disease. Ann Rheum Dis 63:2:ii92–5
Buckley CD, Pilling D, Lord JM, Akbar AN, Scheel-Toellner D, Salmon M
(2001) Fibroblasts regulate the switch from acute resolving to chronic
persistent inflammation. Trends Immunol 22:199–204
Chabot V, Reverdiau P, Iochmann S, Rico A, Senecal D, Goupille C et al.
(2006) CCL5-enhanced human immature dendritic cell migration
through the basement membrane in vitro depends on matrix metallo-
proteinase-9. J Leukoc Biol 79:767–78
Darmanin S, Chen J, Zhao S, Cui H, Shirkoohi R, Kubo N et al. (2007) All-
trans retinoic acid enhances murine dendritic cell migration to draining
lymph nodes via the balance of matrix metalloproteinases and their
inhibitors. J Immunol 179:4616–25
Dudda JC, Simon JC, Martin S (2004) Dendritic cell immunization route
determines CD8+ T cell trafficking to inflamed skin: role for tissue
microenvironment and dendritic cells in establishment of T cell-homing
subsets. J Immunol 172:857–63
Hu Y, Ivashkiv LB (2006) Costimulation of chemokine receptor signaling by
matrix metalloproteinase-9 mediates enhanced migration of IFN-alpha
dendritic cells. J Immunol 176:6022–33
Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive
immune responses. Nat Immunol 5:987–95
Ketloy C, Engering A, Srichairatanakul U, Limsalakpetch A et al. (2008)
Expression and function of Toll-like receptors on dendritic cells and
other antigen presenting cells from non-human primates. Vet Immunol
Immunopathol 125:18–30
Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T et al.
(1994) Impaired immune and acute-phase responses in interleukin-6-
deficient mice. Nature 368:339–42
Kossakowska AE, Edwards DR, Prusinkiewicz C, Zhang MC, Guo D, Urbanski
SJ et al. (1999) Interleukin-6 regulation of matrix metalloproteinase
(MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1)
expression in malignant non-Hodgkin’s lymphomas. Blood 94:2080–9
Lappin MB, Weiss JM, Delattre V, Mai B, Dittmar H, Maier C et al. (1999)
Analysis of mouse dendritic cell migration in vivo upon subcutaneous
and intravenous injection. Immunology 98:181–8
Lin T, Zhang W, Fan Y, Mulholland M (2007) Interleukin-1beta and
interleukin-6 stimulate matrix metalloproteinase-9 secretion in cultured
myenteric glia. J Surg Res 137:38–45
Macagno A, Napolitani G, Lanzavecchia A, Sallusto F (2007) Duration,
combination and timing: the signal integration model of dendritic cell
activation. Trends Immunol 28:227–33
Makela SM, Strengell M, Pietila TE, Osterlund P, Julkunen I (2009) Multiple
signaling pathways contribute to synergistic TLR ligand-dependent
cytokine gene expression in human monocyte-derived macrophages
and dendritic cells. J Leukoc Biol 85:664–72
McIlroy D, Gregoire M (2003) Optimizing dendritic cell-based anticancer
immunotherapy: maturation state does have clinical impact. Cancer
Immunol Immunother 52:583–91
www.jidonline.org 453
A Saalbach et al.
Dermal Fibroblasts Promote the Migration of DCs
Opdenakker G, Van den Steen PE, Dubois B, Nelissen I, Van CE, Masure S
et al. (2001a) Gelatinase B functions as regulator and effector in
leukocyte biology. J Leukoc Biol 69:851–9
Opdenakker G, Van den Steen PE, Van DJ (2001b) Gelatinase B: a tuner and
amplifier of immune functions. Trends Immunol 22:571–9
Ouwehand K, Santegoets SJ, Bruynzeel DP, Scheper RJ, de Gruijl TD, Gibbs S
(2008) CXCL12 is essential for migration of activated Langerhans cells
from epidermis to dermis. Eur J Immunol 38:3050–9
Park JY, Pillinger MH (2007) Interleukin-6 in the pathogenesis of rheumatoid
arthritis. Bull NYU Hosp Jt Dis 65:S4–10
Parsonage G, Falciani F, Burman A, Filer A, Ross E, Bofill M et al. (2003)
Global gene expression profiles in fibroblasts from synovial, skin and
lymphoid tissue reveals distinct cytokine and chemokine expression
patterns. Thromb Haemost 90:688–97
Pease JE, Sabroe I (2002) The role of interleukin-8 and its receptors in
inflammatory lung disease: implications for therapy. Am J Respir Med
1:19–25
Price AA, Cumberbatch M, Kimber I, Ager A (1997) Alpha 6 integrins are
required for Langerhans cell migration from the epidermis. J Exp Med
186:1725–35
Ratzinger G, Stoitzner P, Ebner S, Lutz MB, Layton GT, Rainer C et al. (2002)
Matrix metalloproteinases 9 and 2 are necessary for the migration of
Langerhans cells and dermal dendritic cells from human and murine
skin. J Immunol 168:4361–71
Renkl AC, Wussler J, Ahrens T, Thoma K, Kon S, Uede T et al. (2005)
Osteopontin functionally activates dendritic cells and induces their
differentiation toward a Th1-polarizing phenotype. Blood 106:946–55
Saalbach A, Aneregg U, Bruns M, Schnabel E, Herrmann K, Haustein UF
(1996) Novel fibroblast-specific monoclonal antibodies: properties and
specificities. J Invest Dermatol 106:1314–9
Saalbach A, Arnhold J, Lessig J, Simon JC, Anderegg U (2008) Human Thy-1
induces secretion of matrix metalloproteinase-9 and CXCL8 from human
neutrophils. Eur J Immunol 38:1391–403
Saalbach A, Klein C, Sleeman J, Sack U, Kauer F, Gebhardt C et al. (2007)
Dermal fibroblasts induce maturation of dendritic cells. J Immunol
178:4966–74
Saalbach A, Kraft R, Herrmann K, Haustein UF, Anderegg U (1998) The
monoclonal antibody AS02 recognizes a protein on human fibroblasts
being highly homologous to Thy-1. Arch Dermatol Res 290:360–6
Sangaletti S, Gioiosa L, Guiducci C, Rotta G, Rescigno M, Stoppacciaro A
et al. (2005) Accelerated dendritic-cell migration and T-cell priming in
SPARC-deficient mice. J Cell Sci 118:3685–94
Smith RS, Smith TJ, Blieden TM, Phipps RP (1997a) Fibroblasts as sentinel
cells. Synthesis of chemokines and regulation of inflammation. Am J
Pathol 151:317–22
Smith TJ, Sempowski GD, Berenson CS, Cao HJ, Wang HS, Phipps RP (1997b)
Human thyroid fibroblasts exhibit a distinctive phenotype in culture:
characteristic ganglioside profile and functional CD40 expression.
Endocrinology 138:5576–88
Steinman R, Hoffman L, Pope M (1995) Maturation and migration of
cutaneous dendritic cells. J Invest Dermatol 105:2S–7S
Steinman RM. (2007) Dendritic cells: versatile controllers of the immune
system. Nat Med 13:1155–9
Svensson M, Kaye PM (2006) Stromal-cell regulation of dendritic-cell
differentiation and function. Trends Immunol 27:580–7
Taylor PC, Williams RO, Feldmann M (2004) Tumour necrosis factor alpha as
a therapeutic target for immune-mediated inflammatory diseases. Curr
Opin Biotechnol 15:557–63
Termeer C, Sleeman JP, Simon JC (2003) Hyaluronan—magic glue for the
regulation of the immune response? Trends Immunol 24:112–4
van Helden SF, Krooshoop DJ, Broers KC, Raymakers RA, Figdor CG, van
Leeuwen FN (2006) A critical role for prostaglandin E2 in podosome
dissolution and induction of high-speed migration during dendritic cell
maturation. J Immunol 177:1567–74
Weiss JM, Sleeman J, Renkl AC, Dittmar H, Termeer CC, Taxis S et al. (1997)
An essential role for CD44 variant isoforms in epidermal Langerhans cell
and blood dendritic cell function. J Cell Biol 137:1137–47
Yao JS, Zhai W, Young WL, Yang GY (2006) Interleukin-6 triggers human
cerebral endothelial cells proliferation and migration: the role for KDR
and MMP-9. Biochem Biophys Res Commun 342:1396–404
Yen JH, Khayrullina T, Gnea D (2007) PGE2-induced metalloproteinase-9 is
essential for dendritic cell migration. Blood 111:260–70
Zhang Q, Hui W, Litherland GJ, Barter MJ, Davidson R, Darrah C et al. (2008)
Differential Toll-like receptor-dependent collagenase expression in
chondrocytes. Ann Rheum Dis 67:1633–41
Zhang Y, Cao HJ, Graf B, Meekins H, Smith TJ, Phipps RP (1998) CD40
engagement up-regulates cyclooxygenase-2 expression and prostaglan-
din E2 production in human lung fibroblasts. J Immunol 160:1053–7
Zhao P, Li XG, Yang M, Shao Q, Wang D, Liu S et al. (2008) Hypoxia
suppresses the production of MMP-9 by human monocyte-derived
dendritic cells and requires activation of adenosine receptor A2b via
cAMP/PKA signaling pathway. Mol Immunol 45:2187–95
454 Journal of Investigative Dermatology (2010), Volume 130
A Saalbach et al.
Dermal Fibroblasts Promote the Migration of DCs
